| Overview |
| bsm-61951r-cy3-100ul |
| Lysine tRNA synthetase Recombinant Monoclonal Antibody, Cy3 Conjugated |
| WB, IF(ICC) |
| Human, Mouse, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Lysine tRNA ligase |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3735 |
| Q15046 |
| Extracellular, Cytoplasm, Nucleus, Secreted, Cell membrane |
| CMTRIB; KARS; KARS1; KARS2; KRS; Lysine tRNA ligase; LysRS. |
| Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA.When secreted, acts as a signaling molecule that induces immune response through the activation of monocyte/macrophages. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(ICC) |
1:50-200 |
Powered by Bioz